Stone House Investment Management, LLC
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1696497
TUNKHANNOCK, PA
Position in NAMS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,014
+$611 QoQ
Shares Held
325
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#178
of 197 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stone House Investment Management, LLC holds $549,537 across 70 Biotechnology names. NAMS ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
6,693 | $113,580 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
902 | $85,843 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
1,008 | $55,379 | |
| 4 | INSM |
INSMED Inc
|
501 | $53,416 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
1,000 | $47,040 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78 | $38,744 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
800 | $31,208 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
500 | $16,360 |
All Filings in NAMS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,014 | 325 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $10,403 | 325 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $11,401 | 325 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $9,243 | 325 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $5,885 | 325 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $6,652 | 325 | Shares | Sole | 2025-05-13 | |
| 2024-09-30 | $5,395 | 325 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,243 | 325 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,686 | 325 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||